Your browser doesn't support javascript.
loading
Overexpression of CD99 is associated with tumor adaptiveness and indicates the tumor recurrence and therapeutic responses in gliomas.
Shang, Erfei; Sun, Shanyue; Zhang, Ruolan; Cao, Zehui; Chen, Qingwang; Shi, Leming; Wu, Jinsong; Wu, Shuai; Liu, Yingchao; Zheng, Yuanting.
Afiliação
  • Shang E; Human Phenome Institute, School of Life Sciences, Fudan University, Shanghai, China.
  • Sun S; Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
  • Zhang R; Human Phenome Institute, School of Life Sciences, Fudan University, Shanghai, China.
  • Cao Z; Human Phenome Institute, School of Life Sciences, Fudan University, Shanghai, China.
  • Chen Q; Human Phenome Institute, School of Life Sciences, Fudan University, Shanghai, China.
  • Shi L; Human Phenome Institute, School of Life Sciences, Fudan University, Shanghai, China; Cancer Institute, Shanghai Cancer Center, Fudan University, Shanghai, China.
  • Wu J; Glioma Surgery Division, Neurologic Surgery Department of Huashan Hospital, Fudan University, Shanghai, China.
  • Wu S; Glioma Surgery Division, Neurologic Surgery Department of Huashan Hospital, Fudan University, Shanghai, China. Electronic address: wushuai1991320@163.com.
  • Liu Y; Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China. Electronic address: 13805311573@126.com.
  • Zheng Y; Human Phenome Institute, School of Life Sciences, Fudan University, Shanghai, China. Electronic address: zhengyuanting@fudan.edu.cn.
Transl Oncol ; 37: 101759, 2023 Nov.
Article em En | MEDLINE | ID: mdl-37579711

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Transl Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Transl Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China